Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8705 - 8712 of 11456 results
House Judiciary Committee: Don’t Bank on Immigration Reform
July 17, 2015| Blog| Viewpoint
FCC Releases Declaratory Ruling Clarifying and Expanding the Reach of the Telephone Consumer Protection Act
July 17, 2015| Advisory| Viewpoint
Writing on Her Own Behalf, Chairwoman Ramirez Takes a Position on FRAND
July 17, 2015| Alert| Viewpoint
Can a Move to California Invalidate a Non-Compete?
July 17, 2015| Blog| Viewpoint
DOL Releases Guidance Indicating That Independent Contractor Classification is Restricted to a Narrow Class of Workers
July 16, 2015| Blog| Viewpoint
Trinity Homecare Settlement: Five False Claims Trends
July 15, 2015| Blog| Viewpoint
White House Touts Solar Initiative as Congress Continues Its Busy Summer
July 15, 2015| Blog| Viewpoint
Regulation S safe harbor in EB-5 offerings
July 15, 2015| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.